MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

This publication has 37 references indexed in Scilit:

• Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Fluoxetine Combined with a Serotonin-1A Receptor Antagonist Reversed Reward Deficits Observed during Nicotine and Amphetamine Withdrawal in Rats
  Neuropsychopharmacology, 2001
• Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis
  Neuropsychopharmacology, 1998
• PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
  Annual Review of Pharmacology and Toxicology, 1997
• Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties
  Journal of Medicinal Chemistry, 1997
• The influence of prolonged antidepressant treatment on the changes in cyclic AMP accumulation induced by excitatory amino acids in rat cerebral cortical slices
  NeuroReport, 1995
• Chronic mild stress-induced anhedonia model of depression
  Behavioural Pharmacology, 1995
• Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study
  Journal of Comparative Neurology, 1993
• Metabotropic glutamate receptors in brain function and pathology
  Trends in Pharmacological Sciences, 1993
• Molecular Diversity of Glutamate Receptors and Implications for Brain Function
  Science, 1992